Reflect Scientific, Inc.

Equities

RSCF

US75866F1012

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets 02:29:49 2024-05-21 pm EDT 5-day change 1st Jan Change
0.045 USD -15.73% Intraday chart for Reflect Scientific, Inc. -10.00% -32.33%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Reflect Scientific, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Reflect Scientific Inc. Addresses Rescheduled Freezer Shipment for a $40 Billion BioPharma Company CI
Reflect Scientific, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Reflect Scientific Inc. Announces Successful Testing of Liquid Nitrogen Temperature Control Technology CI
Reflect Scientific Inc. Announces Record-Breaking Freezer Order from Biopharma Company CI
Reflect Scientific, Inc. Secures $200,000 Order from Prominent Bio-Pharma Client for Blast Freezers CI
Reflect Scientific, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Reflect Scientific Inc Receives Order for B-90 Plasma Freezer, Continues to Expand Clientele CI
Reflect Scientific, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Reflect Scientific, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Earnings Flash (RSCF) REFLECT SCIENTIFIC Posts Q3 Revenue $253,233 MT
Reflect Scientific, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Reflect Scientific Inc. Opens New Showroom for Cryometrix Refrigeration and Coldchain Management Products CI
Reflect Scientific, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
California Air Resources Board Recent Amendments to the Airborne Toxic Control Measure for Reefer Transportation Units Favors Reflect Scientific’s Cryogenic Clean Air Reefer’S CI
Earnings Flash (RSCF) REFLECT SCIENTIFIC Posts Q1 Revenue $753,576 MT
Reflect Scientific, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Reflect Scientific, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Earnings Flash (RSCF) REFLECT SCIENTIFIC Posts Q3 Revenue $716,145 MT
Reflect Scientific, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Reflect Scientific Inc. Expands Cryometrix Distribution Channel CI
Reflect Scientific, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Reflect Scientific, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Reflect Scientific, Inc. Announces Sales Results for the Fourth Quarter of 2020 CI
Reflect Scientific, Inc. Announces Continue Strong Orders with an Additional $231,000 in Cryometrix Brand Ultra-Low Temperature Freezers CI
Chart Reflect Scientific, Inc.
More charts
Reflect Scientific, Inc. designs, develops and sells scientific equipment for the life sciences and manufacturing industries. The Company’s product portfolio includes ultra-low temperature freezers, blast freezers, solvent chillers and refrigerated transportation in addition to supplying original equipment manufacturer (OEM) products to the life sciences industry. The Company's brand Cryometrix is an ultra-low temperature and blast freezer design that enables its customers to save substantially on energy costs related to cryogenic storage. The Company also offers Solvent chillers, which are used in natural product extraction for optimizing product yield and purity. Its products range from non-mechanical Cyrometrix freezers and value-added products and components for the life sciences industry to tools and analytical services for industrial manufacturing. Its customers include hospitals, diagnostic laboratories, pharmaceutical and biotech companies, cold chain management and others.
More about the company
  1. Stock Market
  2. Equities
  3. RSCF Stock
  4. News Reflect Scientific, Inc.
  5. Earnings Flash (RSCF) REFLECT SCIENTIFIC Posts Q3 Revenue $253,233
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW